COMMUNIQUÉS West-GlobeNewswire

Rubius Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress
15/05/2019
Enrollment for Phase 1b Trial of RTX-134 for Phenylketonuria on Track for Second Quarter 2019; Initial Clinical Data Anticipated in Second Half 2019 Company Announces Transition of President Torben Straight Nissen, Ph.D [...]
Establishment Labs Reports First Quarter 2019 Financial Results
15/05/2019
NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
Outlook Therapeutics Provides Business Update and Reports Second Quarter Financial Results for Fiscal 2019
15/05/2019
CRANBURY, N.J., May 15, 2019 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK) (the “Company”) today reported business highlights and financial results for its second fiscal quarter ended March 31, 2019. [...]
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
15/05/2019
- Adaptimmune to license Alpine’s Secreted and Transmembrane Immunomodulatory Protein technology for use with SPEAR T-cells to enhance antitumor responses - PHILADELPHIA and OXFORDSHIRE, United Kingdom, May 15, 2019 ( [...]
BioPorto Submits Pediatric Application to FDA for The NGAL Test™ Under Breakthrough Designation
15/05/2019
May 15, 2019 Announcement no. 7 BioPorto Submits Pediatric Application to FDA for The NGAL Test™ Under Breakthrough Designation First test focused on risk assessment of Acute Kidney Injury in pediatric patients BioPorto [...]
Acasti Pharma Awarded Notices of Allowance for Additional Composition & Use Patents in Mexico, Chile and Israel
15/05/2019
LAVAL, Québec, May 15, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
VIVUS Partners with HarborPath Direct to Facilitate Access to PANCREAZE® for Patients Without Health Insurance
15/05/2019
CAMPBELL, Calif. and CHARLOTTE, N.C., May 15, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, and HarborPath Direct, Inc., today announced a partnership to facilitate [...]
North Bud Farms Arranges Private Placement Financing and Provides Corporate Update
15/05/2019
- Insiders of NORTHBUD have Committed $1 Million as Lead Order THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN [...]
BISON CAPITAL ACQUISITION CORP. ANNOUNCES CLOSING OF ITS BUSINESS COMBINATION WITH XYNOMIC PHARMACEUTICALS, INC.
15/05/2019
New York, NY, May 15, 2019 (GLOBE NEWSWIRE) -- Bison Capital Acquisition Corp. (NASDAQ: BCAC) (“BCAC” or the “Company”) today announced that it has closed its business combination with Xynomic Pharmaceuticals, Inc. (“ [...]
Fibrocell Reports First Quarter 2019 Financial Results and Recent Operational Highlights
15/05/2019
Company to Host Conference Call and Webcast Today at 8:30 a.m. EDT EXTON, Pa., May 15, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on transformational autologous cell- [...]
Clearside Biomedical to Present at the UBS Global Healthcare Conference
15/05/2019
ALPHARETTA, Ga., May 15, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
LIDDS completes a directed issue raising SEK 8.9 million
15/05/2019
The board of directors of LIDDS AB has decided to carry out a directed issue of 641.200 shares at a subscription price of SEK 13.85 per share. LIDDS will through the directed share issue receive proceeds amounting to [...]
Articles of Association for NeuroSearch A/S
15/05/2019
Unauthorised translation Articles of Association as of 29.04.2019 enclosed. Attachment NeuroSearch - Vedtægter (UK) - AGM 2019
Symphogen announces new capital raise and explores strategic options
15/05/2019
Copenhagen, 15 May 2019 – Today, Symphogen called for an ordinary shareholders meeting to be held on 29 May 2019. At the meeting, Symphogen’s Board of Directors will propose to raise new capital through a pre-emptive [...]
Oasmia postpones the release of the Q4 and year-end report to 28 June
15/05/2019
The Board of Oasmia has decided to postpone the release of the fourth quarter and year-end 2018/2019 report from 5 June 2019 to 28 June 2019. The delay is a result of the ongoing review initiated by the new Board in [...]
Innate Pharma First Quarter 2019 Report
15/05/2019
Cash, cash equivalents and financial assets of the Company amounted to €237.1 million [*] Initiation of cohort expansion study of monalizumab and cetuximab to evaluate triple combination with an anti-PD(L)1 in patients [...]
Information financière du premier trimestre 2019
15/05/2019
Trésorerie, équivalents de trésorerie et actifs financiers s’élevant à 237,1 millions d’euros [*] Démarrage de l’extension de cohorte étudiant la triple combinaison de monalizumab et cetuximab avec un anti-PD-(L)1 chez [...]
Abeona Therapeutics traite le premier patient dans la deuxième cohorte de l'essai clinique de phase 1/2 pour ABO-101 dans le syndrome de Sanfilippo de type B (MPS IIIB)
15/05/2019
Des données intermédiaires sont attendues au second semestre 2019 NEW YORK et CLEVELAND, 15 mai 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), chef de file totalement intégré dans la thérapie génique [...]
Ritter Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2019
15/05/2019
LOS ANGELES, May 14, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to [...]

Pages